Mandate

Vinge advises Mylan on its offer for Meda

February 12, 2016

Mylan N.V. has announced a recommended public offer to the shareholders of Meda AB (publ) to tender all their shares in Meda to Mylan. The total offer consideration consists of a combination of cash and Mylan ordinary shares. At announcement, the total value of the offer for all Meda shares, including Meda net debt, is approximately SEK 83.6 billion or USD 9.9 billion.
 
In connection with the offer, Mylan has retained Vinge as legal advisor in Sweden. The Vinge team is led by public M&A partners Erik Sjöman and Charlotte Levin and also includes Rikard Lindahl, Anna Edström and Malte Hedlund (on M&A matters), Mikael Ståhl, Louise Brorsson Salomon and Albert Wållgren (on finance matters), Fredrik Gustafsson (on compensation and benefits matters) and Maria Schultzberg (on tax matters).

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026